Trade Aurinia Pharmaceuticals Inc. - AUPH CFD
What is Aurinia Pharmaceuticals Inc. (AUPH)?
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapies for autoimmune and inflammatory diseases. The company’s research focuses on novel treatments aimed at addressing unmet medical needs in conditions such as lupus nephritis. Aurinia’s pipeline includes drug candidates developed through clinical trials and regulatory processes. The company emphasizes scientific innovation and collaboration with healthcare professionals to advance therapeutic options. Its activities encompass drug development, regulatory submissions, and market access strategies. Aurinia Pharmaceuticals operates within the broader pharmaceutical industry, contributing to advancements in disease management and patient care.
Aurinia Pharmaceuticals Inc. Stock Price Today: Live Overview
The price today is shaped by trading activity, as Americana Restaurants International PLC - Foreign Co trades at $15.66. The intraday range extends from $14.99 to $15.51, with a daily change of +0.1296%.
FAQ: Aurinia Pharmaceuticals Inc. (AUPH)
What is the current price of AUPH stock?
The latest price is $15.66.
Does AUPH pay dividends?
Aurinia Pharmaceuticals Inc. does not pay dividends.
Does AUPH have a formal corporate presence or regional headquarters in the UAE?
Aurinia Pharmaceuticals Inc. does not have an official presence in the UAE and operates through distributors.
What is AUPH best known for?
The company is most famous for developing treatments for autoimmune diseases.
What assets are typically shown together with AUPH?
Commonly shown alongside AUPH: TransAlta Corporation Ordinary, Fidelity MSCI Energy Index ETF, State Street SPDR S&P Biotech ETF
Latest shares articles



